Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
PSMA/FOLH1/NAALADase I Antibody (GCP-05), DyLight 650, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP145058C
Description
PSMA/FOLH1/NAALADase I Monoclonal specifically detects PSMA/FOLH1/NAALADase I in Human samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence.Specifications
PSMA/FOLH1/NAALADase I | |
Monoclonal | |
DyLight 650 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
FOLH1 | |
amino acids 44-750 of human GCPII | |
0.1 mL | |
Cancer, Prostate Cancer | |
2346 | |
Human | |
Purified |
Flow Cytometry, Immunocytochemistry, Immunofluorescence | |
GCP-05 | |
Flow Cytometry, Immunocytochemistry/Immunofluorescence | |
Cell growth-inhibiting gene 27 protein, cell growth-inhibiting protein 27, EC 3.4.17.21, folate hydrolase (prostate-specific membrane antigen) 1, Folate hydrolase 1, FOLHNAALADase I, Folylpoly-gamma-glutamate carboxypeptidase, GCP2, GCPIImGCP, glutamate carboxylase II, glutamate carboxypeptidase 2, Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, NAALAD1N-acetylated-alpha-linked acidic dipeptidase I, NAALAdase, N-acetylated alpha-linked acidic dipeptidase 1, prostate specific membrane antigen variant F, Prostate-specific membrane antigen, PSMAFGCP, PSMPteroylpoly-gamma-glutamate carboxypeptidase | |
Mouse | |
Protein A purified | |
RUO | |
Primary | |
The antibody GCP-05 recognizes extracellular domain of glutamate carboxypeptidase II (NAALADase, FOLH1, PSMA), an approximately 95-110 kDa transmembrane glycoprotein expressed mainly in tumour neovasculatures, nervous system and jejunum, which is an important prostate tumour marker. | |
Store at 4C in the dark. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction